-
Analysed healthcare sector to generate key insights related to client’s positioning to face current and future challenges
-
Advised client on investment attractiveness and identified gaps through multilayer risk assessment
CLIENT REQUIREMENTS
- Understand risks and other factors associated with the pharma biotech value chain to determine investment opportunity in the Middle East and Africa (MEA)
OUR APPROACH
- Strategy research
Detailed profiling of risk parameters in MEA for a global pharma major to assess feasibility of investment - Risk assessment
Risk outlook and rating through multilayer assessment and establishing a comparison matrix with a detailed scoring model and weights for each sub-parameter - Valuation analysis
Life sciences and healthcare (LSHC) market overview: Market size, growth rate, segmentation, drivers, trends, challenges, service offerings and growth strategy - Risk characterisation: Identifying potential KRIs and bucketing them within a political, social, economic, technological, legal and environmental framework
- Assessment of KRIs: Assessing KRIs and scoring based on likelihood, impact on pharma value chain and severity
- Comparative analysis: Comparative analysis of individual risks and ranking them in line with the matrix along with key insights
VALUE DELIVERED
- Helped the client understand key risks and other factors associated with the subsectors of the LSHC sector through multilayer risk assessment
- Identified and shortlisted relevant risks aligned with the client’s business and developed a risk assessment model
- Prepared detailed profiles of key risk parameters with a focus on business offering to understand the client’s position in the market
Thank you for sharing your details
Your file will start downloading automatically
If it does not download within 1 minute,
Share this on
